Rafael (NYSE:RFL) Stock Price Down 2.4% – Time to Sell?

Rafael Holdings, Inc. (NYSE:RFL)’s stock price dropped 2.4% during mid-day trading on Thursday . The company traded as low as $1.80 and last traded at $1.84. Approximately 6,243 shares were traded during trading, a decline of 79% from the average daily volume of 29,908 shares. The stock had previously closed at $1.88.

Rafael Stock Performance

The company has a market cap of $45.90 million, a P/E ratio of -1.10 and a beta of 1.15. The business has a 50 day moving average price of $1.99 and a two-hundred day moving average price of $1.88.

Rafael (NYSE:RFL) last announced its quarterly earnings data on Thursday, March 13th. The company reported ($0.06) earnings per share for the quarter. Rafael had a negative net margin of 5,707.03% and a negative return on equity of 53.71%. The company had revenue of $0.08 million during the quarter.

Institutional Investors Weigh In On Rafael

An institutional investor recently raised its position in Rafael stock. Geode Capital Management LLC lifted its position in shares of Rafael Holdings, Inc. (NYSE:RFL) by 24.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 148,068 shares of the company’s stock after purchasing an additional 29,448 shares during the period. Geode Capital Management LLC owned 0.60% of Rafael worth $287,000 as of its most recent SEC filing. 11.30% of the stock is owned by institutional investors and hedge funds.

Rafael Company Profile

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.